Active Ingredient: CARGLUMIC ACID
Proprietary Name: CARGLUMIC ACID
Dosage Form; Route of Administration: TABLET, FOR SUSPENSION; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213729
Product Number: 001
Approval Date: Oct 13, 2021
Applicant Holder Full Name: NOVITIUM PHARMA LLC
Marketing Status:
Prescription
Patent and Exclusivity Information